NCT05161195 2026-02-02
Roll-over Study to Allow Continued Access to Ribociclib
Novartis
Phase 4 Active not recruiting
Clinical Trials
9 trialsNCT02679755 2022-07-27
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
Pfizer
Phase 4 Completed
NCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT00688909 2021-06-09
REAL
Novartis
Phase 4 Completed
NCT00237133 2017-02-24
PREDICT
Novartis
Phase 4 Completed
NCT00014638 2013-02-21
Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
Novartis
Phase 4 Completed
NCT00241046 2012-04-19
Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment
Novartis
Phase 4 Terminated
NCT00171847 2010-03-31
eLEcTRA
Novartis
Phase 4 Terminated
NCT00237224 2009-11-19
Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
Novartis
Phase 4 Completed